Skip to content
Bored Studies
Recruiting

MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients

Health Discovery Labs · with National Institute for Biomedical Imaging and Bioengineering (NIBIB), Mayo Clinic · NCT07362862

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–85 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
50
US sites recruiting
3
Study start
May 5, 2026
Record last updated
July 10, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle weakening.

The main questions this study aims to answer are:

  • Do participants develop medical problems when receiving electrical muscle stimulation in the ICU?
  • Is electrical muscle stimulation a practical way to help reduce muscle weakness in critically ill patients?

Researchers will compare the control group (standard of care) to the intervention group (standard of care plus 60-minute sessions of electrical muscle stimulation daily during the ICU stay) to see if the device is safe and easy to use.

Participants will

  • Receive either standard of care or standard of care plus electrical muscle stimulation of the thigh muscles
  • Have their muscle strength checked during the study
  • Complete a survey three months after ICU discharge to check on their recovery

Being studied: Electrical Muscle Stimulation System

Conditions: Sepsis; Critical Illness; ICU-acquired Muscle Weakness; ICU-acquired Weakness; ICUAW; Sarcopenia; Secondary Sarcopenia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Admitted to ER or ICU within the previous 48 hours
  • APACHE II score ≥ 13
  • Meets the criteria for sepsis or severe sepsis

Exclusion Criteria

  • Anticipated transfer to an ICU not participating in this study
  • Myopathies (e.g. congenital)
  • Acquired myopathies with CK levels 5-times above the upper limit of normal
  • Unable to transfer from bed to chair at baseline
  • Moribund
  • Comfort care
  • New onset deep vein thrombosis within the previous 6-months
  • Malignancy in lower limb
  • Technical obstacles - fracture, burns, amputation
  • Open wound or skin abrasion at the garment application site
  • Pregnancy
  • Pacemaker and implantable cardioverter-defibrillator

Recruiting US locations

  • Mayo Clinic

    Rochester, MN 55905

    Site contact: Division of Nursing Research · 507-422-5523 · RSTnursingresearch@mayo.edu

  • Dell Seton Medical Center at The University of Texas

    Austin, TX 78701

    Site contact: Paul H. Harford, M.D. · 512-963-6362 · PaulHarford@utexas.edu

  • Ascension Seton Medical Center Austin

    Austin, TX 78705

    Site contact: Paul H. Harford, M.D. · 512-963-6362 · PaulHarford@utexas.edu

Study contacts (from the official record)

  • Oussama Hassan, M.D. · 512-203-9474 · O.Hassan@healthdiscoverylabs.com
  • Grace RH McDonough, MD Candidate, Class of 2030 · G.McDonough@healthdiscoverylabs.com
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to… (NCT07362862) | Bored Studies